Biotech Values

[genisi]

I would bet INFORM-2 or perhaps INFORM-3 at least tries adding Ribavirin to the mix and I think we could soon see an exploration of how prior non-responders (to interferon) do.

And I expect they will also try BID for ITMN-191.